The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (NASDAQ: BIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, […]
Healthcare Business Review, a leading publication in the healthcare and dental space, recognizesNuvia Dental Implant Center for a second consecutive year. https://mma.prnewswire.com/media/2493612/Nuvia_Dental_Implant_Center_New_Logo.jpg As a leader in the dental implantology field, Nuvia Dental Implant Center has been named 2025 Dental Implant Restoration Company of the Year Award by the Healthcare Business Review. Recognized for their life-changing
— Company also shares tips on ways to save energy and money as temperatures drop this week;b-roll of energy-saving tips available here As prolonged freezing temperatures continue, Duke Energy continues executing a detailed plan to manage the power grid as customer demand increases. Customer demand is anticipated to peak on Thursday across the Carolinas and
NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zeta Global Holdings Corp. ("Zeta" or "the Company") (NYSE:ZETA). Investors who purchased Zeta securities prior to February 27, 2024, and continue to hold to the present, are encouraged to
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ:SYRE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Spyre and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Oklo Inc. ("Oklo" or the "Company") (NYSE:OKLO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Oklo and certain of its officers and/or directors have
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Franklin Resources, INC. ("Franklin" or the "Company") (NYSE:BEN).��Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com�or 646-581-9980, ext.�7980. The investigation concerns whether Franklin and certain of its officers and/or directors have engaged in
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Icon Public Limited Company ("ICON" or the "Company") (NASDAQ:ICLR).��Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com�or 646-581-9980, ext.�7980. The investigation concerns whether ICON and certain of its officers and/or directors have engaged
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Neurogene Inc. ("Neurogene" or the "Company") (NASDAQ:NGNE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Neurogene and certain of its officers and/or directors have
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. ("Arvinas" or the "Company") (NASDAQ:ARVN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Arvinas and certain of its officers and/or directors have